Plasma Exchange and Intravenous Immunoglobulin in Treatment of Antibody-Mediated Rejection after Kidney Transplantation: Slovenian Experience

被引：0
|
作者：
Gubensek, J. [1 ]
Ponikvar, Buturovic J. [1 ]
Kandus, A. [1 ]
Arnol, M. [1 ]
Kovac, J. [1 ]
Marn-Pernat, A. [1 ]
Lindic, J. [1 ]
Kovac, D. [1 ]
Ponikvar, R. [1 ]
机构：
[1] Univ Med Ctr Ljubljana, Dept Nephrol, Ljubljana, Slovenia
来源：
TRANSPLANTATION | 2012年 / 94卷 / 10期
关键词：
D O I：
10.1097/00007890-201211271-02030
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
840
引用
收藏
页码：1026 / 1026
页数：1
相关论文
共 50 条
  • [21] Comparison of Clinical Characteristics and Outcomes of Early Antibody-Mediated Rejection and Late Antibody-Mediated Rejection after Kidney Transplantation
    Chen, G.
    Wu, Z.
    Wang, C.
    Liu, X.
    Li, Q.
    Chen, L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 846 - 846
  • [22] Treatment of Antibody-Mediated Rejection After Kidney Transplantation-10 Years' Experience With Apheresis at a Single Center
    Gubensek, Jakob
    Buturovic-Ponikvar, Jadranka
    Kandus, Aljosa
    Arnol, Miha
    Lindic, Jelka
    Kovac, Damjan
    Rigler, Andreja Ales
    Romozi, Karmen
    Ponikvar, Rafael
    [J]. THERAPEUTIC APHERESIS AND DIALYSIS, 2016, 20 (03) : 240 - 245
  • [23] Antibody-Mediated Rejection in Kidney Transplantation: A Review
    Puttarajappa, Chethan
    Shapiro, Ron
    Tan, Henkie P.
    [J]. JOURNAL OF TRANSPLANTATION, 2012, 2012
  • [24] Daratumumab for treatment of antibody-mediated rejection after ABO-incompatible kidney transplantation
    Spica, Davide
    Junker, Till
    Dickenmann, Michael
    Schaub, Stefan
    Steiger, Jurg
    Rufli, Tanja
    Halter, Jorg
    Hopfer, Helmut
    Holbro, Andreas
    Hirt-Minkowski, Patricia
    [J]. SWISS MEDICAL WEEKLY, 2019, : 14S - 15S
  • [25] Rituximab and intravenous immunoglobulin treatment for chronic antibody-mediated renal allograft rejection
    Fehr, T.
    Gaspert, A.
    Ruesi-Elsener, B.
    Weber, M.
    Fischer, A.
    Wuethrich, R. P.
    [J]. SWISS MEDICAL WEEKLY, 2008, 138 (47-48) : 15S - 15S
  • [26] Daratumumab for Treatment of Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
    Spica, Davide
    Junker, Till
    Dickenmann, Michael
    Schaub, Stefan
    Steiger, Jurg
    Rufli, Tanja
    Halter, Jorg
    Hopfer, Helmut
    Holbro, Andreas
    Hirt-Minkowski, Patricia
    [J]. CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2019, 9 (03): : 149 - 157
  • [27] Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation
    Muller, Yannick D.
    Ghaleb, Nseir
    Rotman, Samuel
    Vionnet, Julien
    Halfon, Matthieu
    Catana, Emmanuelle
    Golshayan, Dela
    Venetz, Jean-Pierre
    Aubert, Vincent
    Pascual, Manuel
    [J]. TRANSPLANT INTERNATIONAL, 2018, 31 (04) : 451 - 455
  • [28] RITUXIMAB, INTRAVENOUS IMMUNOGLOBULIN, PLAMAPHERESIS? HOW TREAT CHRONIC ANTIBODY-MEDIATED KIDNEY REJECTION?
    Maisin, Anne
    Macher, Marie-Alice
    Peuchmaur, Michel
    Deschenes, Georges
    Suberbielle, Caroline
    Baudouin, Veronique
    [J]. PEDIATRIC TRANSPLANTATION, 2011, 15 : 52 - 52
  • [29] RITUXIMAB AS MONOTHERAPY FOR THE TREATMENT OF CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION
    Muller, Yannick
    Ghaleb, Nseir
    Rotman, Samuel
    Catana, Emmanuelle
    Golshayan, Dela
    Venetz, Jean-Pierre
    Aubert, Vincent
    Pascual, Manuel
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 553 - 554
  • [30] Indicators of Treatment Responsiveness to Rituximab and Plasmapheresis in Antibody-Mediated Rejection After Kidney Transplantation
    Immenschuh, Stephan
    Zilian, Eva
    Daemmrich, Max E.
    Schwarz, Anke
    Gwinner, Wilfried
    Becker, Jan Ulrich
    Blume, Cornelia A.
    [J]. TRANSPLANTATION, 2015, 99 (01) : 56 - 62
12345